Factors Associated with the Remission of Insomnia After Traumatic Brain Injury: a Traumatic Brain Injury Model Systems Study
Overview
Authors
Affiliations
: To examine the factors associated with the remission of insomnia by examining a sample of individuals who had insomnia within the first two years after traumatic brain injury (TBI) and assessing their status at a secondary time point.: Secondary data analysis from a multicenter longitudinal cohort study. A sample of 40 individuals meeting inclusion criteria completed a number of self-report scales measuring sleep/wake characteristics (Pittsburgh Sleep Quality Index, Epworth Sleepiness Scale, Insomnia Severity Index, Sleep Hygiene Index), fatigue and depression (Multidimensional Assessment of Fatigue, Patient Health Questionnaire-9), and community participation (Participation Assessment with Recombined Tools-Objective). One cohort was followed at 1 and 2 years post-injury (n = 19) while a second cohort was followed at 2 and 5 years post-injury (n = 21).: Remission of insomnia was noted in 60% of the sample. Those with persistent insomnia had significantly higher levels of fatigue and depression at their final follow-up and poorer sleep hygiene across both follow-up time-points. A trend toward reduced community participation among those with persistent insomnia was also found.: Individuals with persistent post-TBI insomnia had poorer psychosocial outcomes. The chronicity of post-TBI insomnia may be associated with sleep-related behaviors that serve as perpetuating factors.
Fu Z, Miao X, Luo X, Yuan L, Xie Y, Huang S Front Neurosci. 2024; 18:1484777.
PMID: 39554848 PMC: 11564178. DOI: 10.3389/fnins.2024.1484777.
Howell S, Griesbach G Neurotrauma Rep. 2024; 5(1):3-12.
PMID: 38249321 PMC: 10797171. DOI: 10.1089/neur.2023.0093.
Hanks R, Ketchum J, Peckham M, Sevigny M, Sander A, Martin A J Head Trauma Rehabil. 2024; 39(1):18-30.
PMID: 38167716 PMC: 10807629. DOI: 10.1097/HTR.0000000000000921.
Gottshall J, Guedes V, Pucci J, Brooks D, Watson N, Sheth P Front Pharmacol. 2022; 12:762077.
PMID: 35153739 PMC: 8829004. DOI: 10.3389/fphar.2021.762077.